TumorSight Viz

JSON twin: https://www.healthaidb.com/software/tumorsight-viz.json

Company Name

SimBioSys

Product URL

https://simbiosys.com/products/tumorsight-viz

Company URL

https://simbiosys.com/

Categories

• clinical Care
• diagnostic Support
• patient Facing
• Clinical
• Diagnostic

Summary

TumorSight Viz is an FDA-cleared, AI-powered software that transforms breast MRI scans into detailed 3D visualizations, aiding surgeons in precise preoperative planning for breast cancer surgeries.

Description

TumorSight Viz utilizes standard breast MRI images to generate 3D spatial visualizations of breast cancer, providing key metrics such as tumor volume, tumor-to-breast volume, and distances to anatomical structures. This assists surgeons in making informed decisions regarding breast-conserving surgery or mastectomy options. The software integrates seamlessly with hospital PACS systems, streamlining workflow and enhancing surgical precision. It has received multiple FDA 510(k) clearances, with the latest in July 2025, and is available for clinical use in the United States. TumorSight Viz is developed by SimBioSys, a clinical AI company specializing in precision medicine for cancer care.

Api Available

unknown

Certifications

• FDA 510(k) clearance

Company Founding

2020

Company Offices

• United States

Compliance

• HIPAA
• FDA 510(k) clearance

Customers

Data Residency

US

Data Standards

• DICOM

Deployment Model

• SaaS

Features

• 3D spatial visualization of breast cancer using DCE MRI
• Automatic tumor segmentation with AI
• Accurate volume measurements for pre-surgical planning
• Tumor-to-landmark measurements for surgical decision-making
• Conversion of prone MRI to supine position for enhanced visualization

Id

SW0137

Integration Partners

Integrations

• PACS systems

Languages Supported

• English

Last Updated

2025-10-11

License

commercial

Market Segment

• enterprise

Optional Modules

• Clinical Decision Support (CDS) application

Os Platforms

• Web

Pricing Details

contact vendor

Pricing Model

subscription

Privacy Features

• Data anonymization
• Compliance with healthcare privacy regulations

Product Code

SW0137

Product Name

TumorSight Viz

Ratings

Regions Available

• United States

Related Urls

• https://www.fda.gov/medical-devices/software-medical-device-samd/artificial-intelligence-enabled-medical-devices

Release Year

Security Features

• End-to-end encryption
• Secure data storage

Specialties

• Breast Cancer

Support Channels

System Requirements

Target Users

• clinicians
• surgeons
• patients

Training Options

Type

product

User Reviews

Version

1.0

Alternatives

See related products

Canonical JSON

{
  "product_name": "TumorSight Viz",
  "company_name": "SimBioSys",
  "product_url": "https://simbiosys.com/products/tumorsight-viz",
  "company_url": "https://simbiosys.com/",
  "related_urls": [
    "https://www.fda.gov/medical-devices/software-medical-device-samd/artificial-intelligence-enabled-medical-devices"
  ],
  "product_code": "SW0137",
  "summary": "TumorSight Viz is an FDA-cleared, AI-powered software that transforms breast MRI scans into detailed 3D visualizations, aiding surgeons in precise preoperative planning for breast cancer surgeries.",
  "description": "TumorSight Viz utilizes standard breast MRI images to generate 3D spatial visualizations of breast cancer, providing key metrics such as tumor volume, tumor-to-breast volume, and distances to anatomical structures. This assists surgeons in making informed decisions regarding breast-conserving surgery or mastectomy options. The software integrates seamlessly with hospital PACS systems, streamlining workflow and enhancing surgical precision. It has received multiple FDA 510(k) clearances, with the latest in July 2025, and is available for clinical use in the United States. TumorSight Viz is developed by SimBioSys, a clinical AI company specializing in precision medicine for cancer care.",
  "categories": [
    "clinical Care",
    "diagnostic Support",
    "patient Facing",
    "Clinical",
    "Diagnostic",
    "Patient-facing"
  ],
  "market_segment": [
    "enterprise"
  ],
  "target_users": [
    "clinicians",
    "surgeons",
    "patients"
  ],
  "specialties": [
    "Breast Cancer"
  ],
  "regions_available": [
    "United States"
  ],
  "languages_supported": [
    "English"
  ],
  "pricing_model": "subscription",
  "pricing_details": "contact vendor",
  "license": "commercial",
  "company_offices": [
    "United States"
  ],
  "company_founding": "2020",
  "deployment_model": [
    "SaaS"
  ],
  "os_platforms": [
    "Web"
  ],
  "features": [
    "3D spatial visualization of breast cancer using DCE MRI",
    "Automatic tumor segmentation with AI",
    "Accurate volume measurements for pre-surgical planning",
    "Tumor-to-landmark measurements for surgical decision-making",
    "Conversion of prone MRI to supine position for enhanced visualization"
  ],
  "optional_modules": [
    "Clinical Decision Support (CDS) application"
  ],
  "integrations": [
    "PACS systems"
  ],
  "data_standards": [
    "DICOM"
  ],
  "api_available": "unknown",
  "system_requirements": "",
  "compliance": [
    "HIPAA",
    "FDA 510(k) clearance"
  ],
  "certifications": [
    "FDA 510(k) clearance"
  ],
  "security_features": [
    "End-to-end encryption",
    "Secure data storage"
  ],
  "privacy_features": [
    "Data anonymization",
    "Compliance with healthcare privacy regulations"
  ],
  "data_residency": "US",
  "customers": [],
  "user_reviews": [],
  "ratings": [],
  "support_channels": [],
  "training_options": [],
  "release_year": "",
  "integration_partners": [],
  "id": "SW0137",
  "slug": "tumorsight-viz",
  "type": "product",
  "version": "1.0",
  "last_updated": "2025-10-11",
  "links_json": {
    "self": "https://www.healthaidb.com/software/tumorsight-viz.json"
  }
}